Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

2.

Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.

McKenney JM, Sica D.

Pharmacotherapy. 2007 May;27(5):715-28. Review.

PMID:
17461707
3.

Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia.

Hoy SM, Keating GM.

Drugs. 2009 May 29;69(8):1077-105. doi: 10.2165/00003495-200969080-00008. Review.

PMID:
19496632
4.

Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.

Rupp H.

Adv Ther. 2009 Jul;26(7):675-90. doi: 10.1007/s12325-009-0045-2. Epub 2009 Jul 27. Review.

PMID:
19629408
5.

Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids.

Bays H.

Am J Cardiol. 2006 Aug 21;98(4A):71i-76i. Epub 2006 May 30. Review.

PMID:
16919519
6.

Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia.

McKenney JM, Sica D.

Am J Health Syst Pharm. 2007 Mar 15;64(6):595-605. Review.

PMID:
17353568
7.
8.

Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia.

Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM.

Expert Opin Pharmacother. 2008 May;9(7):1237-48. doi: 10.1517/14656566.9.7.1237. Review.

PMID:
18422480
9.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
10.

Treatment of diabetic dyslipidemia.

Garg A.

Am J Cardiol. 1998 Feb 26;81(4A):47B-51B. Review.

PMID:
9526814
11.

Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids.

Brunton S, Collins N.

Curr Med Res Opin. 2007 May;23(5):1139-45. Review. Erratum in: Curr Med Res Opin. 2008 Jan;24(1):247.

PMID:
17519081
12.
13.

Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects.

Kar S.

Am J Ther. 2014 Jan-Feb;21(1):56-66. doi: 10.1097/MJT.0b013e31822b5603. Review.

PMID:
21975796
14.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
15.

Short-term effects of omega-3 fatty acids on exercise stress test parameters, angina and lipoproteins.

Vacek JL, Harris WS, Haffey K.

Biomed Pharmacother. 1989;43(5):375-9. Review.

PMID:
2551411
16.
17.

Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.

Bays HE, Tighe AP, Sadovsky R, Davidson MH.

Expert Rev Cardiovasc Ther. 2008 Mar;6(3):391-409. doi: 10.1586/14779072.6.3.391. Review.

PMID:
18327998
18.

Prescription omega-3-acid ethyl esters for the treatment of very high triglycerides.

Sadovsky R, Kris-Etherton P.

Postgrad Med. 2009 Jul;121(4):145-53. doi: 10.3810/pgm.2009.07.2020. Review.

PMID:
19641280
19.

Serum triglycerides and clinical benefit in lipid-lowering trials.

Kesäniemi YA.

Am J Cardiol. 1998 Feb 26;81(4A):70B-73B. Review.

PMID:
9526818
20.

Triglycerides and coronary risk in women and the elderly.

LaRosa JC.

Arch Intern Med. 1997 May 12;157(9):961-8. Review.

PMID:
9140266
Items per page

Supplemental Content

Write to the Help Desk